VIGIL NEUROSCIENCE, INC.

Profile

Company Names

VIGIL NEUROSCIENCE, INC.

Addresses

1 BROADWAY, 7TH FLOOR, SUITE 07-300, CAMBRIDGE, MA 02142

300 TECH SQUARE 8TH FLOOR, 8TH FLOOR, CAMBRIDGE, MA 02139

300 TECHNOLOGY SQUARE, 8TH FLOOR, CAMBRIDGE, MA 02139

400 TECHNOLOGY SQUARE, 10TH FLOOR, CAMBRIDGE, MA 02139

Phone Numbers

857-254-4445

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY, OTHER

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$214,999,655.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2022-08-16 
$74,999,705.00 
$74,999,705.00 
$0.00 
Equity 
2
2021-08-13 
$89,999,961.00 
$89,999,961.00 
$0.00 
Equity 
1
2020-09-18 
$49,999,989.00 
$49,999,989.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHERYL 
 
BLANCHARD 
DIRECTOR
BIO2 TECHNOLOGIES, INC.   |  DARE BIOSCIENCE, INC.   |  VIGIL NEUROSCIENCE, INC.
CHERYL 
 
BLANCHARD, PH. D. 
DIRECTOR
VIGIL NEUROSCIENCE, INC.
BRUCE 
 
BOOTH 
DIRECTOR
MIRAGEN THERAPEUTICS INC   |  AVILA THERAPEUTICS INC   |  ZAFGEN, INC.   |  NIMBUS DISCOVERY, LLC   |  ON-Q-ITY, INC.   |  NUMERATE INC   |  UNUM THERAPEUTICS, INC.   |  LYSOSOMAL THERAPEUTICS, INC.   |  AVROBIO, INC.   |  MAGENTA THERAPEUTICS, INC.   |  ATLAS VENTURE FUND XI, L.P.   |  RODIN THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND I, L.P.   |  ATLAS VENTURE FUND XII, L.P.   |  VIGIL NEUROSCIENCE, INC.   |  ATLAS VENTURE OPPORTUNITY FUND II, L.P.   |  ATLAS VENTURE FUND XIII, L.P.   |  MATCHPOINT THERAPEUTICS INC.   |  ATLAS VENTURE FUND XIV, L.P.   |  ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
SUZANNE 
 
BRUHN 
DIRECTOR
PLIANT THERAPEUTICS, INC.   |  VIGIL NEUROSCIENCE, INC.   |  MIND MEDICINE (MINDMED) INC.
SHAAN 
 
GANDHI 
DIRECTOR
DICE MOLECULES HOLDINGS, LLC   |  STRIDEBIO, INC.   |  VIGIL NEUROSCIENCE, INC.   |  GARUDA THERAPEUTICS, INC.   |  CAMP4 THERAPEUTICS CORP   |  TRANSITION BIO, INC.
GERHARD 
 
KOENIG 
DIRECTOR
VIGIL NEUROSCIENCE, INC.
IVANA 
 
MAGOVCEVIC-LIEBISCH 
EXECUTIVE OFFICER, DIRECTOR
ABSCI CORP   |  VIGIL NEUROSCIENCE, INC.   |  AEGLEA BIOTHERAPEUTICS, INC.
SPYROS 
 
PAPAPETROPOULOS 
EXECUTIVE OFFICER
VIGIL NEUROSCIENCE, INC.
EVAN 
 
THACKABERRY 
EXECUTIVE OFFICER
VIGIL NEUROSCIENCE, INC.
MARY 
 
THISTLE 
DIRECTOR
COCOON BIOTECH INC.   |  VIGIL NEUROSCIENCE, INC.
CLAY 
 
THORP 
DIRECTOR
PHASEBIO PHARMACEUTICALS INC   |  CANCERGUIDE DIAGNOSTICS, INC.   |  PATHFINDER THERAPEUTICS, INC.   |  CLEARSIDE BIOMEDICAL, INC.   |  G-ZERO THERAPEUTICS, INC.   |  GENECENTRIC DIAGNOSTICS, INC.   |  G1 THERAPEUTICS, INC.   |  LYSOSOMAL THERAPEUTICS, INC.   |  ORIG3N, INC.   |  STRIDEBIO, INC.   |  GENECENTRIC THERAPEUTICS, INC.   |  VIGIL NEUROSCIENCE, INC.   |  PIPR THERAPEUTICS, INC.
CHRISTOPHER 
 
VERNI 
EXECUTIVE OFFICER
VIGIL NEUROSCIENCE, INC.
STEFAN 
 
VITOROVIC 
DIRECTOR
VIDA VENTURES, LLC   |  VVAG SPECIAL FUND LLC   |  PRAXIS PRECISION MEDICINES, INC.   |  VIDA VENTURES II, LLC   |  VIDA VENTURES II-A, LLC   |  TECTONIC THERAPEUTIC, INC.   |  VIGIL NEUROSCIENCE, INC.   |  VOLASTRA THERAPEUTICS, INC.   |  TECTONIC THERAPEUTIC, INC.
JENNIFER 
 
ZIOLKOWSKI 
EXECUTIVE OFFICER
SOLID BIOSCIENCES INC.   |  VIGIL NEUROSCIENCE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-08-29
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2022-08-16 
2021-08-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-13 
2021-06-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-18 
2020-10-05
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
JEFFERIES LLC
2347